Animal health intelligence
Syntera connects animal disease, vaccine markets and economic decisions — turning epidemiological signals and livestock forecasts into figures that stand up to scrutiny, with every assumption on the page.
Products
Each is a live piece of work rather than a brochure. Two run inside Syntera, two are independent applications with their own access.
In this workspace
FMD vaccine demand, supply scenarios, country gaps, producer landscape and serotype signals — computed from the dataset in this project, with controls you set yourself.
External application
Independent observatory for bluetongue virus situation tracking, running at btv.syntera.global with its own access arrangements.
External application
Analytical workbench for exploratory animal-health economics work, published as a standalone research tool.
External application
Live biological risk intelligence application for structured animal-health risk assessment, running at risk.syntera.global with its own access arrangements.
About
Veterinary and agricultural economist. Founder of Syntera and author of the models behind these tools.
Who this is for
Where requirement, funding and strain profile actually line up.
Scenario arithmetic you can interrogate line by line.
An unfunded gap is a financing question, not a revenue line.
Evidence principles
These are the constraints applied to every chart and table across Syntera. The full formulas, limitations and source list are on the methods page.
Read the methodsOpen research
Market structure · 5 min analysis
A cattle population is not a market. Turning epidemiological need into purchased doses requires a policy decision, a budget line and a procurement process — and each of those can fail independently.
21 September 2026Supply · 4 min analysis
Installed antigen capacity, catalogue capacity and shippable doses of a matched strain are three different quantities. Confusing them makes shortages look impossible right up to the point they happen.
21 September 2026Strain matching · 4 min analysis
Knowing that serotype O is circulating tells you which shelf to look at. It does not tell you whether the vaccine on that shelf will protect the animals in front of you.
21 September 2026If you are sizing a vaccine market, designing a campaign, appraising a financing mechanism or checking someone else's numbers, say what decision you are trying to make and what evidence you already hold.